The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …

Pancreatic cysts are being identified with increasing frequency as a result of the escalating
use of crosssectional imaging, typically for unrelated reasons. 1, 2 The incidence of …

Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …

Abstract The ACR Incidental Findings Committee (IFC) presents recommendations for
managing pancreatic cysts that are incidentally detected on CT or MRI. These …

Pancreatic cancer is the 4 th leading cause of cancer-related death in Western countries.
Considering the low incidence of pancreatic cancer, population-based screening is not …

Background: Current diagnosis and staging of pancreatic ductal adenocarcinoma (PDAC)
has important limitations and better biomarkers are needed to guide initial therapy. We …

Objective: Previous nomogram models for patients undergoing resection of intraductal
papillary mucinous neoplasms (IPMNs) have been relatively small single-institutional series …

OBJECTIVES: The management of small and incidental branch duct intraductal papillary
mucinous neoplasms (BD-IPMNs) still is of concern. The aim is assessing the safety of a …

Purpose While surveillance of the majority of patients with IPMN is considered best practice,
consensus regarding the duration of follow-up is lacking. This study assessed the survival …

BACKGROUND: Little is known about the risk of subsequently developing a new or
progressive intraductal papillary mucinous neoplasm (IPMN) after partial pancreatic …